Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by The Good GP. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Good GP or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Understanding DoxyPep: STI Prevention Strategies with Dr Christine Dykstra

21:45
 
Share
 

Manage episode 485109192 series 3296340
Content provided by The Good GP. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Good GP or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode of The Good GP, host Karin Sekhon is joined by Dr Christine Dykstra, a specialist sexual health physician at Royal Perth Hospital and Sexual Health North. They discuss the emerging topic of doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmitted infections (STIs).

Dr Dykstra provides an overview of Doxy-PEP, describing it as the use of 200 mg doxycycline taken within 24 (but up to 72) hours after at-risk sexual contact, primarily to reduce the risk of bacterial STIs such as syphilis and chlamydia in target populations. The emerging gonococcal resistance to tetracyclines issue was also addressed.

Focusing on identifying appropriate candidates for Doxy-PEP, with current data supporting its use predominantly in gay and bisexual men and trans women at high risk—particularly those who have had syphilis or two bacterial STIs in the past year.

They also discussed the potential risks, primarily antimicrobial resistance, and the importance of patient education and regular STI testing as part of safe Doxy-PEP prescribing.

Dr Dykstra also discusses the level of awareness and uptake of Doxy-PEP in Australia, which remains low, and reinforces the importance of clinician engagement in providing accurate information and safe prescribing for those who may benefit.

Links & Resources:


The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network.

If you have any questions or would like to contact The Good GP, send an email to [email protected]. Visit www.thegoodgp.com.au for previous episodes and more information.

Mentioned in this episode:

Curious about how Lyrebird Health can fit into your workflow?

Curious about how Lyrebird Health can fit into your workflow? Visit our website, explore case studies, and even connect with our team for a personalised demo. We're here to help!

Lyrebird Health 1

  continue reading

217 episodes

Artwork
iconShare
 
Manage episode 485109192 series 3296340
Content provided by The Good GP. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Good GP or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode of The Good GP, host Karin Sekhon is joined by Dr Christine Dykstra, a specialist sexual health physician at Royal Perth Hospital and Sexual Health North. They discuss the emerging topic of doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmitted infections (STIs).

Dr Dykstra provides an overview of Doxy-PEP, describing it as the use of 200 mg doxycycline taken within 24 (but up to 72) hours after at-risk sexual contact, primarily to reduce the risk of bacterial STIs such as syphilis and chlamydia in target populations. The emerging gonococcal resistance to tetracyclines issue was also addressed.

Focusing on identifying appropriate candidates for Doxy-PEP, with current data supporting its use predominantly in gay and bisexual men and trans women at high risk—particularly those who have had syphilis or two bacterial STIs in the past year.

They also discussed the potential risks, primarily antimicrobial resistance, and the importance of patient education and regular STI testing as part of safe Doxy-PEP prescribing.

Dr Dykstra also discusses the level of awareness and uptake of Doxy-PEP in Australia, which remains low, and reinforces the importance of clinician engagement in providing accurate information and safe prescribing for those who may benefit.

Links & Resources:


The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network.

If you have any questions or would like to contact The Good GP, send an email to [email protected]. Visit www.thegoodgp.com.au for previous episodes and more information.

Mentioned in this episode:

Curious about how Lyrebird Health can fit into your workflow?

Curious about how Lyrebird Health can fit into your workflow? Visit our website, explore case studies, and even connect with our team for a personalised demo. We're here to help!

Lyrebird Health 1

  continue reading

217 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play